Hong Ren
Impact in
-
- Lymphoma Diagnosis and Treatment
-
- CAR-T cell therapy research
- Lung Cancer Research Studies
Papers in
-
- Lymphoma Diagnosis and Treatment 5
-
- Ocular Oncology and Treatments 3
- Co-authors
- Zhiping Tan (1 shared paper)Albrecht Moritz (1 shared paper)Ting‐Lei Gu (1 shared paper)Gregory Innocenti (1 shared paper)Yifeng Yang (1 shared paper)Katherine Crosby (1 shared paper)Jianmin Ren (1 shared paper)Xin Zhu (1 shared paper)
- Journals
- Advanced Science (3 papers)Blood (3 papers)Phytomedicine (1 paper)Acta Biochimica et Biophysica Sinica (1 paper)Cancer Research (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Hong Ren
14 papers receiving 336 citations
Peers
Comparison fields: 5 of 58
- Pathology and Forensic Medicine 95
- Oncology 113
- Immunology 57
- Genetics 26
- Dermatology 21
Countries citing papers authored by Hong Ren
This map shows the geographic impact of Hong Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Ren more than expected).
Fields of papers citing papers by Hong Ren
This network shows the impact of papers produced by Hong Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Ren. The network helps show where Hong Ren may publish in the future.
Co-authors
The 25 scholars most cited alongside Hong Ren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 100 | |
| 2 | 2021 | 60 | |
| 3 | 2018 | 54 | |
| 4 | 2024 | 37 | |
| 5 | 2023 | 34 | |
| 6 | 2022 | 18 | |
| 7 | 2013 | 14 | |
| 8 | 2018 | 10 | |
| 9 | 2016 | 5 | |
| 10 | 2017 | 3 | |
| 11 | 2024 | 3 | |
| 12 | 2025 | 1 | |
| 13 | 2025 | 1 | |
| 14 | 2026 | 1 |
About Hong Ren
Hong Ren is a scholar working on Pathology and Forensic Medicine, Ophthalmology, Oncology, Dermatology and Immunology, having authored 14 papers that have together received 341 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (5 papers), Ocular Oncology and Treatments (3 papers), CAR-T cell therapy research (2 papers), Immunotherapy and Immune Responses (2 papers), Cutaneous lymphoproliferative disorders research (2 papers), Nanoplatforms for cancer theranostics (2 papers), RNA modifications and cancer (1 paper) and Ovarian cancer diagnosis and treatment (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (95 citations), Oncology (113 citations), Immunology (57 citations), Genetics (26 citations) and Dermatology (21 citations). Hong Ren has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Zhiping Tan, Albrecht Moritz, Ting‐Lei Gu, Gregory Innocenti, Yifeng Yang, Katherine Crosby, Jianmin Ren, Xin Zhu, Zhihong Deng and Sean A. Beausoleil. Their work appears in journals such as Advanced Science, Blood, Phytomedicine, Acta Biochimica et Biophysica Sinica and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.